NASDAQ$BTMD
biote Corp · Q1 2026 earnings
Q1 2026 earnings · · Investor relations
Briefing
Biote reported Q1 2026 revenue of $44.9M and net income attributable to stockholders of $2.3M as earnout liability gain offset lower operating income.
For the quarter ended March 31, 2026, Biote generated revenue of $44.9 million versus $49.0 million a year ago. Operating income was $3.2 million. Net income attributable to biote Corp. stockholders was $2.3 million compared with $13.7 million in Q1 2025 when a larger earnout liability gain boosted results.
- Revenue $44.9M; product revenue $43.9M.
- Net income to stockholders $2.3M.
- Operating income $3.2M vs $9.7M prior year.
- Hormone wellness clinic network model.
Headline financials
Revenue & EPS history
biote · Revenue · Quarterly
$44.9M
Forward guidance
Clinic partner growth and procedure volumes drive revenue; earnout and fair-value items can swing quarterly net income.
Tailwinds
- Remained profitable on GAAP basis.
- Recurring pellet procedure revenue model.
Headwinds
- Revenue down YoY.
- Lower operating income ex earnout gains.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q1 2026
-2.4%
Avg return
Earnings day
-4.0%
Avg return
5 days after
-3.0%
Avg return
30 days after
55%
11 / 20 earnings
Positive
+16.9%
Q3 2024
Best reaction
-25.1%
Q4 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.9% | -9.6% | +4.6% | |
| Q4 2025 | -10.5% | -20.9% | -7.6% | |
| Q3 2025 | -2.4% | -11.1% | -13.0% | |
| Q1 2025 | +11.3% | +17.1% | +14.7% | |
| Q4 2024 | -25.1% | -0.7% | -11.0% | |
| Q3 2024 | +16.9% | -6.3% | +13.7% | |
| Q2 2024 | -21.2% | -17.8% | -10.6% | |
| Q1 2024 | +0.2% | +1.0% | +11.1% | |
| Q4 2023 | +11.9% | +27.0% | +10.1% | |
| Q3 2023 | -20.2% | -18.4% | -0.9% | |
| Q2 2023 | -14.4% | -22.0% | -23.7% | |
| Q1 2023 | -17.2% | -14.3% | -20.6% | |
| Q4 2022 | +16.6% | +34.9% | +33.3% | |
| Q3 2022 | +2.3% | +2.5% | +7.2% | |
| Q2 2022 | +1.1% | -4.6% | -7.4% | |
| Q1 2022 | +0.6% | -36.9% | -64.3% | |
| Q4 2021 | +0.0% | +0.0% | +0.6% | |
| Q3 2021 | -0.1% | +0.1% | +1.0% | |
| Q2 2021 | +0.0% | -0.5% | -0.2% | |
| Q1 2021 | +0.6% | +0.6% | +3.0% | |
| Q4 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro